The Selectivity Challenge
Many biologics struggle to distinguish diseased tissue from healthy tissue, limiting their safety and efficacy potential.
- Disease targets can closely resemble healthy targets.
- Subtle structural features can control binding.
- Protein interactions are dynamic, not static.
- The design space is too large to test experimentally.